is trulicity a glp-1 (Dulaglutide) Injection Pre-filled Pens 1.5 mg — Mountainside Medical Trulicity (Dulaglutide) Injection Pre-filled Pens
Description
These drugs are currently approved in India only under strict medical conditions and are designated as prescription-only medications
It's currently in Phase 3 trials and has only received approval in Mexico
& Roy, D
Patent expiry in March 2026 invites further generics, potentially accelerating volume but pressuring branded margins within the Latin America GLP-1 agonists market
Novo Nordisk is studying CagriSema in six late-stage clinical trials and could release data from a 68-week study in obese patients later this year
